These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25595840)

  • 1. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside.
    Jinushi M; Komohara Y
    Biochim Biophys Acta; 2015 Apr; 1855(2):123-30. PubMed ID: 25595840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
    Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Promise of Targeting Macrophages in Cancer Therapy.
    Brown JM; Recht L; Strober S
    Clin Cancer Res; 2017 Jul; 23(13):3241-3250. PubMed ID: 28341752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.
    Quail DF; Joyce JA
    Clin Cancer Res; 2017 Feb; 23(4):876-884. PubMed ID: 27895033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF-1/CSF-1R targeting agents in clinical development for cancer therapy.
    Ries CH; Hoves S; Cannarile MA; Rüttinger D
    Curr Opin Pharmacol; 2015 Aug; 23():45-51. PubMed ID: 26051995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clever-1/stabilin-1 controls cancer growth and metastasis.
    Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
    Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
    Chen P; Bonaldo P
    Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target validation using RNA interference in solid tumors.
    Aharinejad S; Sioud M; Lucas T; Abraham D
    Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of and strategies for overcoming resistance to anti-vascular endothelial growth factor therapy in non-small cell lung cancer.
    Huang Y; Carbone DP
    Biochim Biophys Acta; 2015 Apr; 1855(2):193-201. PubMed ID: 25598052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.
    Bonelli S; Geeraerts X; Bolli E; Keirsse J; Kiss M; Pombo Antunes AR; Van Damme H; De Vlaminck K; Movahedi K; Laoui D; Raes G; Van Ginderachter JA
    FEBS J; 2018 Feb; 285(4):777-787. PubMed ID: 28834216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages: The Road Less Traveled, Changing Anticancer Therapy.
    Guerriero JL
    Trends Mol Med; 2018 May; 24(5):472-489. PubMed ID: 29655673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor-infiltrating macrophages to combat cancer.
    Panni RZ; Linehan DC; DeNardo DG
    Immunotherapy; 2013 Oct; 5(10):1075-87. PubMed ID: 24088077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.
    Mitchem JB; Brennan DJ; Knolhoff BL; Belt BA; Zhu Y; Sanford DE; Belaygorod L; Carpenter D; Collins L; Piwnica-Worms D; Hewitt S; Udupi GM; Gallagher WM; Wegner C; West BL; Wang-Gillam A; Goedegebuure P; Linehan DC; DeNardo DG
    Cancer Res; 2013 Feb; 73(3):1128-41. PubMed ID: 23221383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour endothelial cells acquire drug resistance in a tumour microenvironment.
    Hida K; Akiyama K; Ohga N; Maishi N; Hida Y
    J Biochem; 2013 Mar; 153(3):243-9. PubMed ID: 23293323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.
    Long KB; Collier AI; Beatty GL
    Mol Immunol; 2019 Jun; 110():3-12. PubMed ID: 29273393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. License for destruction: tumor-specific cytokine targeting.
    Johansson A; Hamzah J; Ganss R
    Trends Mol Med; 2014 Jan; 20(1):16-24. PubMed ID: 24169116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.
    Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D
    Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.